Philippine Society of Orthomolecular Medicine

03/01/2026

Emerging evidence demonstrates that vitamin D supplementation achieving serum levels above 40 ng/mL is associated with a 30-50% reduction in autoimmune disease activity, with mechanistic studies revealing direct effects on regulatory T cell function and inflammatory cytokine production.

Join us and learn more on the EMERGING autoimmune, immune diseases and cancer protocols.

Tinyurl.com/PSOM2026

01/01/2026

Applications to the Diplomate training program is now closed

Thank you for your interest

31/12/2025

Bountiful 2026 to ALL

31/12/2025

Even low doses of prednisone increase the risk for fracture, with clinically meaningful harm emerging within months rather than years. Daily doses of 2.5-7.5 mg raise the risk for fracture as early as 5-6 months after treatment initiation, according to an international review published in The Lancet Diabetes & Endocrinology. http://ms.spr.ly/6186torRg

31/12/2025

Last day for the Early Bird rates

Happy New Year!!!

29/12/2025

to the rescue

26/12/2025

Vit d3 correction to >40ng/ml reduced recurrent heart attacks by 50%

A new study reports a 50% reduction in repeat heart attacks using targeted Vitamin D3. But the real breakthrough isn’t Vitamin D, it’s precision prevention. The TARGET-D study has created a real stir in cardiology circles, not because it turns Vitamin D into a miracle pill, but because it shows ...

26/12/2025

5 days before Early Bird rates ENDS

24/12/2025

🚨 A new peer-reviewed analysis in Molecular Oncology highlights the potential of routine daily vitamin D supplementation for adults aged 50+ to prevent approximately 30,000 cancer deaths annually in Germany alone.

This is driven by a consistent ~13% reduction in cancer mortality, as demonstrated across multiple meta-analyses of randomized controlled trials (RCTs).

Key findings from the study:

• Lives saved: ~30,000 fewer cancer deaths per year in Germany

• Life-years gained: ~322,000 life-years saved annually

• Cost per person: ~€11–€55 (approx. $12–$60 USD) per year

• Total supplementation cost: ~€1.0 billion annually

• Net healthcare savings: ~€280 million ($300 million USD) per year, due to reduced end-of-life cancer care expenses

• Cost per life-year saved (conservative estimate, ignoring care savings): ~€3,100—far below thresholds for new cancer drugs

This intervention is supported by over 900 recent studies detailing vitamin D's anti-cancer mechanisms, including:

• Suppression of tumor growth, proliferation, metastasis, and epithelial-to-mesenchymal transition (EMT)

• Induction of cell death (apoptosis and ferroptosis)

• Immune modulation and improved tumor microenvironment control

• Enhanced response to chemotherapy and immunotherapy, with reduced treatment resistance

Benefits observed across multiple cancers, such as breast (including triple-negative), prostate, colorectal, ovarian, lung, melanoma, bladder, and more.

Low vitamin D levels are linked to worse prognosis and more aggressive disease, while adequate levels correlate with better survival.

In contrast to modern oncology drugs—which often cost tens of thousands per patient for marginal survival gains of weeks or months—vitamin D offers a low-cost, evidence-based option that could shift focus toward effective prevention and lower overall healthcare spending.

As the analysis notes: "The only real question left is why public health policy continues to ignore it."

Especially relevant during winter months when vitamin D levels typically decline—consider discussing testing and supplementation with your healthcare provider.

🔗 https://febs.onlinelibrary.wiley.com/doi/10.1002/1878-0261.12924

🔗 https://www.sciencedirect.com/science/article/pii/S0960076023000638

🔗 Full article: https://www.thefocalpoints.com/p/vitamin-d-could-prevent-30000-cancer

19/12/2025

Vitamin C, also known as ascorbic acid, has sparked controversy since it first emerged as a potential anti-cancer agent. However, an increasing number…

18/12/2025

16/12/2025